World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
70
Citations
31152
World Ranking
2367
National Ranking
96

Nathalie Chaput publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Nathalie Chaput sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 216 publications — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Nathalie Chaput D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Nathalie Chaput sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 70 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Nathalie Chaput is affiliated with the Institut Gustave Roussy in France. Their research primarily spans the field of Medicine, with a strong focus on Oncology, Pulmonary and Respiratory Medicine, Immunology, Cancer Research, and Molecular Biology. The scientist's body of work includes 158 publications across these domains.

The main topics addressed in their research include:

  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Renal cell carcinoma treatment
  • Lung Cancer Research Studies
  • Lung Cancer Treatments and Mutations
  • Cancer Genomics and Diagnostics
  • Immune cells in cancer

Several recent papers authored by or involving Nathalie Chaput highlight research in cancer immunotherapy and related clinical insights. Key publications include:

  • "Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer," 2020, Nature Communications
  • "Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report," 2020, Annals of Oncology
  • "Tumour burden and efficacy of immune-checkpoint inhibitors," 2021, Nature Reviews Clinical Oncology
  • "Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis," 2022, European Journal of Cancer
  • "Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy," 2020, Clinical Cancer Research

The scientist frequently publishes in several venues, most notably:

  • Annals of Oncology
  • European Journal of Cancer
  • Journal for ImmunoTherapy of Cancer
  • Journal of Clinical Oncology
  • Clinical Cancer Research

Nathalie Chaput collaborates regularly with other researchers. Frequent co-authors include:

  • Marie Naigeon
  • Benjamin Besse
  • Aurélien Marabelle
  • Lydie Cassard
  • Laurence Albigès

Best Publications

  • Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

    Marie Vétizou;Marie Vétizou;Marie Vétizou;Jonathan M. Pitt;Jonathan M. Pitt;Jonathan M. Pitt;Romain Daillère;Romain Daillère;Romain Daillère;Patricia Lepage

  • Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death.

    Noelia Casares;Marie O. Pequignot;Antoine Tesniere;François Ghiringhelli

  • Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

    Bernard Escudier;Thierry Dorval;Nathalie Chaput;Fabrice André

  • Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper

    Thomas Lener;Mario Gimona;Ludwig Aigner;Verena Börger

  • Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab.

    N. Chaput;P. Lepage;C. Coutzac;C. Coutzac;E. Soularue;E. Soularue

  • Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1.

    Stephane Champiat;Stephane Champiat;Laurent Dercle;Samy Ammari;Christophe Massard

  • CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner

    Francois Ghiringhelli;Cédric Ménard;Magali Terme;Caroline Flament

  • Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer.

    Laura Mezquita;Edouard Auclin;Roberto Ferrara;Melinda Charrier

  • Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC

    Benjamin Besse;Mélinda Charrier;Valérie Lapierre;Eric Dansin

  • Exosomes: immune properties and potential clinical implementations

    Nathalie Chaput;Clotilde Théry;Clotilde Théry

  • The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy.

    Lionel Apetoh;François Ghiringhelli;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;Alfredo Criollo;Alfredo Criollo;Alfredo Criollo

  • Exosomes as Potent Cell-Free Peptide-Based Vaccine. I. Dendritic Cell-Derived Exosomes Transfer Functional MHC Class I/Peptide Complexes to Dendritic Cells

    Fabrice André;Nathalie Chaput;Nöel E. C. Schartz;Caroline Flament

  • A novel dendritic cell subset involved in tumor immunosurveillance.

    Julien Taieb;Nathalie Chaput;Cédric Ménard;Lionel Apetoh

  • Dendritic Cell-Derived Exosomes Promote Natural Killer Cell Activation and Proliferation: A Role for NKG2D Ligands and IL-15Rα

    Sophie Viaud;Sophie Viaud;Magali Terme;Magali Terme;Caroline Flament;Caroline Flament;Julien Taieb;Julien Taieb

  • Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy.

    Yuting Ma;Laetitia Aymeric;Clara Locher;Stephen R Mattarollo

  • Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer.

    Clélia Coutzac;Jean Mehdi Jouniaux;Jean Mehdi Jouniaux;Angelo Paci;Angelo Paci;Julien Schmidt;Julien Schmidt

  • Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway

    Laurence Zitvogel;Oliver Kepp;Laura Senovilla;Laurie Menger

  • IL-18 induces PD-1-dependent immunosuppression in cancer.

    Magali Terme;Evelyn Ullrich;Laetitia Aymeric;Kathrin Meinhardt

  • Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival

    J. Delyon;C. Mateus;D. Lefeuvre;E. Lanoy

  • Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

    Nicolas F. Delahaye;Sylvie Rusakiewicz;Sylvie Rusakiewicz;Isabelle Martins;Cédric Ménard;Cédric Ménard

  • Dendritic Cell-Derived Exosomes for Cancer Immunotherapy: What's Next?

    Sophie Viaud;Clotilde Théry;Stéphanie Ploix;Thomas Tursz

  • Applying extracellular vesicles based therapeutics in clinical trials

    Thomas Lener;Mario Gimona;Ludwig Aigner;Verena Börger

Frequent Co-Authors

Laurence Zitvogel
Laurence Zitvogel University of Paris-Saclay
Benjamin Besse
Benjamin Besse University of Paris-Saclay
David Planchard
David Planchard Institut Gustave Roussy
Guido Kroemer
Guido Kroemer Université Paris Cité
Caroline Robert
Caroline Robert University of Paris-Saclay
Fabrice Andre
Fabrice Andre Institut Gustave Roussy
Jean-Charles Soria
Jean-Charles Soria Amgen (United States)
François Ghiringhelli
François Ghiringhelli Centre Georges François Leclerc
Alexander M.M. Eggermont
Alexander M.M. Eggermont Institut Gustave Roussy
Bernard Escudier
Bernard Escudier Institut Gustave Roussy

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Nursing is a popular pathway, often complementing immunology knowledge with clinical practice. Many students pursue accelerated RN to NP programs to quickly advance clinical expertise while specializing in patient care.

Non-nurses looking to enter the field can consider online RN programs for non nurses in Florida, which provide flexible access to nursing education without prior medical experience. These programs help bridge foundational science with applied healthcare skills relevant to immunology careers.

Students worried about competitive admissions may find success with the easiest accelerated nursing programs to get into, which offer streamlined entry into Bachelor of Science in Nursing degrees. These options balance accessibility with rigorous training to prepare graduates for fast-paced healthcare roles.

For those seeking a quicker route into clinical roles, which LPN programs are easiest to get into can be a practical choice. Licensed Practical Nurse programs provide essential patient care experience and can be a stepping stone toward advanced immunology-related professions.

Best Scientists Citing Nathalie Chaput

Trending Scientists

Recently Published Articles